Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
304.00    0.00 (0.00%)
Bid:
304.00
Ask:
304.50
Spread: 0.50 (0.164%)
Market Cap: £179.47m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Transaction in Own Shares

28 May 2025 07:00

RNS Number : 2952K
Treatt PLC
28 May 2025
 

28 May 2025

TREATT PLC

("Treatt" or the "Company")

Transaction in Own Shares

TREATT PLC ("Treatt" or the "Company") announces today it has purchased the following number of its ordinary shares of 2p each ("Ordinary Shares") through Peel Hunt LLP as part of its share buyback programme, details of which were announced by Treatt on 10 April 2025.

 Date of purchase

 27 May 2025

 Number of common shares purchased:

 138,488

 Lowest price paid per share (pence):

 275.50

 Highest price paid per share (pence):

 278.25

 Weighted average price per day (pence):

 277.08

The Company intends to hold the purchased Ordinary Shares in treasury. Following the purchase and settlement of these Ordinary Shares, the Company will hold 1,637,260 of its Ordinary Shares in treasury and will have 59,641,802 Ordinary Shares in issue (excluding treasury shares). The total number of shares held in the Employee Benefit Trust and Treatt SIP Trust, under which voting rights are waived, is 391,711. Therefore, the total number of voting rights in the Company is 59,250,091 and this figure may be used by shareholders in their calculations when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases made as part of the buyback programme.

Aggregate information:

 Venue

 Volume Weighted Average Price (p)

 Aggregated Volume

 Lowest price per share (p)

 Highest price per share (p)

XLON

 277.08

 138,488

 275.50

 278.25

Individual transactions:

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company is detailed below:

 Number of shares purchased

 Price (pence per share)

 Trading Venue

 Time of transaction

 Transaction Reference

10,000

278.25

XLON

09:00:08

00177419659TRLO0

25,000

277.00

XLON

09:55:21

00177426102TRLO0

55,000

277.00

XLON

11:50:00

00177436139TRLO0

20,000

275.50

XLON

14:32:32

00177449476TRLO0

28,488

278.00

XLON

16:15:48

00177469170TRLO0

  For further enquiries: Treatt PLC Nick Hartigan General Counsel and Company Secretary 01284 702500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQDLFLEELFBBK
Date   Source Headline
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report
5th Apr 20174:41 pmRNSHolding(s) in Company
3rd Apr 20175:25 pmRNSDirector/PDMR Shareholding
31st Mar 20173:57 pmRNSTotal Voting Rights
30th Mar 20177:00 amRNSTrading Statement
27th Mar 20179:30 amRNSHolding(s) in Company
24th Mar 20173:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:50 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
23rd Feb 20177:00 amRNSTrading Statement
20th Feb 20174:03 pmRNSDirector/PDMR Shareholding
14th Feb 20178:15 amRNSHolding(s) in Company
10th Feb 20179:41 amRNSHolding(s) in Company
1st Feb 20172:19 pmRNSDirector/PDMR Shareholding
30th Jan 20175:58 pmRNSNotification of a Transaction of a Director
27th Jan 20174:42 pmRNSResult of AGM
27th Jan 20177:15 amRNSTrading Statement
30th Dec 20167:00 amRNSAnnual Information Update
30th Dec 20167:00 amRNSTotal Voting Rights
22nd Dec 20163:11 pmRNSUpdate on Site Relocation
20th Dec 201610:26 amRNSDirector/PDMR Shareholding
13th Dec 20161:11 pmRNSNotification of Transactions of Directors
9th Dec 20163:05 pmRNSAnnual Financial Report
5th Dec 20164:35 pmRNSBlock listing Interim Review
1st Dec 20162:55 pmRNSVoting Rights and Capital
29th Nov 20167:00 amRNSFinal Results
31st Oct 20164:45 pmRNSDirector/PDMR Shareholding
19th Oct 20162:51 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTrading Update
29th Sep 20161:21 pmRNSTotal Voting Rights
27th Sep 20163:24 pmRNSHolding(s) in Company
22nd Sep 20163:36 pmRNSDirector/PDMR Shareholding
6th Sep 20163:04 pmRNSHolding(s) in Company
5th Sep 201610:41 amRNSHolding(s) in Company
1st Sep 20163:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.